Issue 1/2002
Content (10 Articles)
Loss of BRCA1 expression in sporadic male breast carcinoma
Xiaoping Sun, Yun Gong, M. Sambasiva Rao, Sunil Badve
Inhibition of myc-dependent breast tumor formation in transgenic mice
Wei Cui, Barry A. Gusterson, A. John Clark
Involvement of breast epithelial-stromal interactions in the regulation of protein tyrosine phosphatase-γ (PTPγ) mRNA expression by estrogenically active agents
Suling Liu, Samuel K. Kulp, Yasuro Sugimoto, Jiahua Jiang, Hsiang-lin Chang, Young C. Lin
Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells
T. Kiefer, P. T. Ram, L. Yuan, S. M. Hill
Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth
Chun-Hong Zhu, Frederick E. Domann
Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study
Annette Pernille Høyer, Anne-Marie Gerdes, Torben Jørgensen, Fritz Rank, Helle Bøggild Hartvig
Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer
Shinichi Tsutsui, Shinji Ohno, Shigeru Murakami, Yoichi Hachitanda, Shinya Oda
Overexpression of MDM2 oncoprotein correlates with possession of estrogen receptor alpha and lack of MDM2 mRNA splice variants in human breast cancer
Masao Hori, Jiro Shimazaki, Satoshi Inagawa, Masayuki Itabashi, Mitsuo Hori
Preservation of histopathologic assessment by use of a special technique for tissue inactivation by radiofrequency
Sylvia H. Heywang-Köbrunner, Wieland Weiwad, Dieter Lampe, Jörg Buchmann